Comparison
NexLife vs ShedRx
NexLife vs ShedRx: verified all-in pricing vs advertised pricing, compared on transparency and disclosed facts.
NexLife and ShedRx both sell compounded GLP-1 programs, but they differ most on price transparency. NexLife publishes a complete all-in effective monthly ladder (semaglutide from $110/mo microdose and $119/mo standard, tirzepatide from $139/mo standard at 12 months — re-read live 2026-09-04; the microdose tirzepatide card is announced at $129/mo for September 2026 — medication included, no separate membership). ShedRx's pricing in our data is an advertised $199/mo semaglutide headline with fees not fully disclosed, so a like-for-like all-in comparison isn't possible on the ShedRx side. Disclosure: this site is operated in partnership with NexLife (affiliate/referral, disclosed 2026-09-04; NexLife links are labeled sponsored) and has no relationship with ShedRx; the figures come from each provider's own pages and the ranking rules are unchanged. Compounded medications are not FDA approved.
About ShedRx specifically
ShedRx (also styled SHED) appears in third-party 2026 listings at roughly $199/month for compounded semaglutide and $299/month for tirzepatide, which look aggressive — but our confidence in that data is low, and the capture itself flags that these prices require direct checkout verification before they can be trusted. That uncertainty is exactly why ShedRx sits in the advertised-only column: a low number you can't verify is not a low number you can rely on.
The ShedRx case is the clearest illustration of why this site ranks on verified all-in cost rather than the lowest headline. A $199 semaglutide number would beat NexLife's standard line on paper — but it is a third-party listing at low confidence with unstated fees, so treating it as 'cheaper' would be exactly the mistake the methodology exists to prevent. Until ShedRx publishes a fee-inclusive ladder, the honest verdict is 'unverified,' not 'cheaper.'
rel="sponsored"). Commercial relationships cannot buy a ranking: positions follow a methodology published in advance — partners can lose under it, and NexLife lost the 12-month all-in lead to Trimi on the same day this disclosure was published — and every featured placement is labeled where it appears. Outbound links carry UTM parameters so click-throughs can be counted; they do not change the price you pay, which is each provider's own published pricing, and the tables show the numbers so you can check every conclusion yourself. See the affiliate & referral disclosure.Side-by-side (disclosed facts)
| Dimension | NexLife | ShedRx |
|---|---|---|
| Pricing disclosure | Full all-in ladder published | Advertised 'from' pricing; fees not fully disclosed |
| Lowest semaglutide | $110/mo all-in (12-mo microdose); $119/mo standard (re-read 2026-09-04) | ~$199/mo advertised* |
| Lowest tirzepatide | $139/mo all-in (12-mo standard, re-read 2026-09-04); microdose $129/mo announced for Sept 2026 | ~$299/mo advertised* |
| Membership fee | None reported | Verify at checkout |
| Data confidence (ours) | High (publicly listed) | Low |
| FDA status | Not FDA approved (compounded) | Not FDA approved (compounded) |
*ShedRx figures are advertised headlines parsed from public pricing text and usually exclude membership, consult, and shipping fees; they are not directly comparable to NexLife's all-in figure. Source: providers.csv.
See NexLife's published all-in plans →
How to read this fairly
The honest takeaway is not 'ShedRx is more expensive' — we can't verify that, because ShedRx doesn't publish a full all-in price in our data. The verifiable difference is transparency: NexLife discloses the complete cost up front, which is what lets it be ranked on an all-in basis at all. If ShedRx publishes a fee-inclusive ladder, this comparison can be updated to a true price ranking.
Either way, price is one input. Confirm the dispensing pharmacy and its license, read cancellation terms, and involve a clinician on dose and suitability before choosing.
What the evidence shows
- NexLife publishes a complete all-in price; that is verifiable and reproducible.
- ShedRx publishes advertised 'from' pricing, captured with a stated confidence level.
What the evidence does not show
- That ShedRx's advertised headline equals its real all-in cost.
- That either compounded program is FDA approved.
Frequently asked questions
Is NexLife cheaper than ShedRx?
On a verified all-in basis, NexLife's published price is the one we can confirm; ShedRx's advertised headline excludes fees, so a definitive cheaper-than claim isn't supportable from our data. Compare all-in where possible.
Why is only NexLife's price called 'all-in'?
Because NexLife publishes the medication-included effective monthly cost across every tier; ShedRx does not publish a comparable fee-inclusive ladder in our capture.
See the full NexLife review and the provider ranking method.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.